THE ECONOMIC IMPACT OF LINEZOLID FOR THE MANAGEMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) IN THE CHILEAN PREVISIONAL HEALTH INSTITUTIONS (ISAPRE)

被引：0

作者：

Mould-Quevedo, J. F. ^{[1
]}

Vargas Zea, N. ^{[2
]}

Diaz-Sotelo, O. D. ^{[3
]}

Villamil Munevar, V. ^{[3
]}

Ortiz, Vecino A. ^{[4
]}

机构：

[1] Pfizer Inc, New York, NY USA

[2] Pfizer SAS, Bogota, Colombia

[3] RANDOM Fdn, Bogota, DC, Colombia

[4] Johns Hopkins Univ, Baltimore, MD USA

来源：

VALUE IN HEALTH | 2013年 / 16卷 / 03期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A84 / A84

页数：1

共 50 条

[41] What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?
Dumitrescu, O.
Lina, G.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 1 - 2
[42] ASSESSING ANTIMICROBIAL SUCCESS RATES IN THE TREATMENT OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI): A BAYESIAN META-ANALYSIS
Logman, J. F. S.
Treur, M. J.
Verheggen, B. G.
Heeg, B. M. S.
Stephens, J. M.
Haider, S.
Cappelleri, J. C.
Nathwani, D.
Tice, A.
Van Hout, B. A.
VALUE IN HEALTH, 2008, 11 (06) : A428 - A428
[43] Detection and Initial Management of Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus
Sawyer, Robert G.
SURGICAL INFECTIONS, 2008, 9 : S11 - S15
[44] DaptomycinA Review of its Use in the Management of Complicated Skin and Soft-Tissue Infections and Staphylococcus aureus Bacteraemia
Philip I. Hair
Susan J. Keam
Drugs, 2007, 67 : 1483 - 1512
[45] Daptomycin -: A review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia
Hair, Philip I.
Keam, Susan J.
DRUGS, 2007, 67 (10) : 1483 - 1512
[46] Economic outcomes of inappropriate initial antibiotic treatment for complicated skin and soft tissue infections: a multicenter prospective observational study
Lipsky, B. A.
Napolitano, L. M.
Moran, G. J.
Vo, L.
Nicholson, S.
Chen, S.
Boulanger, L.
Kim, M.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 79 (02) : 266 - 272
[47] BUDGET IMPACT ANALYSIS OF CEFTAROLINE VERSUS LINEZOLID OR VANCOMYCIN ON THE TOP OF STANDARD THERAPY IN THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUES INFECTIONS IN RUSSIAN FEDERATION
Kulikov, A.
Komarov, I
VALUE IN HEALTH, 2013, 16 (07) : A345 - A345
[48] COST-EFFECTIVENESS ANALYSIS OF LINEZOLID AND VANCOMYCIN IN PATIENTS WITH COMPLICATED SKIN AND SOFT-TISSUE INFECTIONS CAUSED BY METHICILIN-RESISTANT STAPHYLOCOCCUS IN PORTUGAL
Ines, M.
Saramago, P.
Pinto, A.
VALUE IN HEALTH, 2013, 16 (07) : A506 - A506
[49] Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus
Itani, Kamal M. F.
Dryden, Matthew S.
Bhattacharyya, Helen
Kunkel, Mark J.
Baruch, Alice M.
Weigelt, John A.
AMERICAN JOURNAL OF SURGERY, 2010, 199 (06): : 804 - 816
[50] European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10years of experience with linezolid
Bassetti, M.
Baguneid, M.
Bouza, E.
Dryden, M.
Nathwani, D.
Wilcox, M.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 3 - 18

← 1 2 3 4 5 →